Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsInfectious Disease

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1462972

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1462972

Influenza Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Test Kit and Reagents, Others); By Test Type; By End Use; By Region; Segment Forecast, 2024- 2032

PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2032, according to a new study by Polaris Market Research. The report "Influenza Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Test Kit and Reagents, Others); By Test Type; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The influenza diagnostics market is growing due to heightened awareness and concerns about influenza globally. With influenza's contagious nature and potential for severe illness, there's increasing emphasis on early detection and management. Annual outbreaks underscore the necessity for accurate diagnosis to mitigate its impact on individuals and healthcare systems. Additionally, the economic and societal repercussions of influenza outbreaks drive demand for effective diagnostic solutions. The COVID-19 pandemic has further highlighted respiratory infection risks, fueling demand for diagnostic testing. Advanced technologies like rapid point-of-care tests and molecular assays offer faster, more accurate results, contributing to market growth.

Elderly individuals and those with chronic diseases are especially susceptible to severe influenza complications, necessitating timely and accurate diagnostics. With global demographics shifting towards aging populations and rising chronic conditions, demand for influenza diagnostic solutions is heightened. Elderly individuals often have compromised immune systems, elevating their influenza risk. Similarly, those with chronic ailments face increased vulnerability. Healthcare providers prioritize early influenza detection in these groups to prevent complications. Additionally, the burden of influenza on healthcare systems intensifies with aging populations and chronic conditions, driving the need for effective diagnostic tools.

Remote monitoring and telemedicine solutions enable healthcare providers to diagnose influenza remotely, minimizing the need for in-person visits. Patients can consult healthcare professionals from home, reducing exposure to infectious diseases. Telemedicine platforms integrate diagnostic tools like remote temperature monitoring devices and digital thermometers for real-time symptom assessment. Wearable technology continuously monitors vital signs, aiding influenza diagnosis. Additionally, these solutions optimize resource allocation and reduce healthcare costs. By facilitating timely diagnosis and treatment, they enhance patient outcomes and disease management.

The influenza diagnostics market is also witnessing a surge in demand driven by the growing adoption of multiplex assays. These assays enable simultaneous detection of various pathogens, including influenza viruses and other respiratory pathogens, in a single test. They offer faster turnaround times, reduced sample volumes, and enhanced diagnostic accuracy. Multiplex assays streamline workflows, improve patient management strategies, and conserve resources by minimizing the need for multiple tests. As healthcare systems focus on enhancing their capacity for diagnosing respiratory infections, the demand for multiplex assays is expected to continue rising, fueling market growth.

Influenza Diagnostics Market Report Highlights

In 2023, the test kit and reagents segment held a significant revenue share owing to wide adoption in healthcare settings, high demand during flu seasons, and government initiatives and pandemic preparedness.

In 2023, the RIDT segment held a significant revenue share owing to rapid results, cost-effectiveness, and established usage.

In 2023, the hospital's segment held a significant revenue share owing to high patient footfall, comprehensive healthcare services, and access to specialized equipment.

In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare spending, and the strong presence of key market players.

The market is highly competitive owing to the existence of market players with a global presence, including Abbott Laboratories, Becton, Dickinson and Company (BD), bioMerieux SA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. among others.

Polaris Market Research has segmented the Influenza Diagnostics market report based on product, test type, end use, and region:

Influenza Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Test Kit and Reagents
  • Others

Influenza Diagnostics, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • RIDT
  • Cell Culture
  • RT-PCR
  • Others

Influenza Diagnostics, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Others

Influenza Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Show more
Product Code: PM4663

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Influenza Diagnostics Market Insights

  • 4.1. Influenza Diagnostics Market - End Use Snapshot
  • 4.2. Influenza Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of influenza is projected to spur product demand
      • 4.2.1.2. Increasing adoption of point-of-care testing is expected to drive influenza diagnostics market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges and compliance requirements are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Influenza Diagnostics Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Influenza Diagnostics Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • 5.3. RIDT
    • 5.3.1. Global Influenza Diagnostics Market, by RIDT, by Region, 2019-2032 (USD Billion)
  • 5.4. Cell Culture
    • 5.4.1. Global Influenza Diagnostics Market, by Cell Culture, by Region, 2019-2032 (USD Billion)
  • 5.5. RT-PCR
    • 5.5.1. Global Influenza Diagnostics Market, by RT-PCR, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Influenza Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Influenza Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Test Kit and Reagents
    • 6.4.1. Global Influenza Diagnostics Market, by Test Kit and Reagents, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Influenza Diagnostics Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Influenza Diagnostics Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global Influenza Diagnostics Market, by Diagnostic Laboratories, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Influenza Diagnostics Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Influenza Diagnostics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Influenza Diagnostics Market - North America
    • 8.3.1. North America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Influenza Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Influenza Diagnostics Market - Canada
      • 8.3.5.1. Canada: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Influenza Diagnostics Market - Europe
    • 8.4.1. Europe: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Influenza Diagnostics Market - UK
      • 8.4.4.1. UK: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Influenza Diagnostics Market - France
      • 8.4.5.1. France: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Influenza Diagnostics Market - Germany
      • 8.4.6.1. Germany: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Influenza Diagnostics Market - Italy
      • 8.4.7.1. Italy: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Influenza Diagnostics Market - Spain
      • 8.4.8.1. Spain: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Influenza Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Influenza Diagnostics Market - Russia
      • 8.4.10.1. Russia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Influenza Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Influenza Diagnostics Market - China
      • 8.5.4.1. China: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Influenza Diagnostics Market - India
      • 8.5.5.1. India: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Influenza Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Influenza Diagnostics Market - Japan
      • 8.5.7.1. Japan: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Influenza Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Influenza Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Influenza Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Influenza Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Influenza Diagnostics Market - UAE
      • 8.6.5.1. UAE: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Influenza Diagnostics Market - Israel
      • 8.6.6.1. Israel: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Influenza Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Influenza Diagnostics Market - Latin America
    • 8.7.1. Latin America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Influenza Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Influenza Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Influenza Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company (BD)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux SA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CorisBioConcept
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. DiaSorin S.p.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GenMark Diagnostics, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hologic, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Luminex Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Meridian Bioscience, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Quidel Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. SA Scientific, Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Sekisui Diagnostics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Thermo Fisher Scientific Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
Show more
Product Code: PM4663

List of Tables

  • Table 1 Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 2 Global Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 4 Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 6 North America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 UK: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 18 UK: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 France: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 21 France: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 China: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 42 China: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 44 India: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 45 India: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Influenza Diagnostics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Influenza Diagnostics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Test Type
  • Figure 9. Global Influenza Diagnostics Market, by Test Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Influenza Diagnostics Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 12. Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Influenza Diagnostics Market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!